最近在准免疫系统治疗高血压方面取得了进展
Rikeish R Muralitharan1, Francine Z Marques2, Joanne A O'Donnell3
1Hypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, VIC, Australia; Victorian Heart Institute, Monash University, Clayton, Australia.
European journal of pharmacology
|September 20, 2024
概括
高血压 (高血压) 影响全球超过10亿成年人. 新的研究探索了针对免疫系统和炎症的新疗法,以更好地控制血压.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高血压是全球主要的死亡原因,超过13亿成年人受到影响,特别是在低收入和中等收入国家.
- 很大一部分高血压患者的血压不受控制,由于诊断,治疗和治疗反应的挑战,增加了心血管事件的风险.
- 目前的治疗方法,包括单疗法和组合疗法,往往无法达到目标血压水平,因此需要开发新的治疗策略.
研究的目的:
- 审查免疫系统在高血压发展和调节中的复杂作用.
- 评估现有的临床试验,研究抗炎药物和细胞因子阻断用于高血压管理.
- 确定临床前和临床数据中的知识差距,并为免疫向高血压治疗提出未来方向.
主要方法:
- 关于免疫系统参与高血压的科学文献的综述.
- 对抗炎症药物 (胆固醇,甲铁酸盐) 和细胞因子抑制剂 (IL-1β,TNF-α) 的临床试验数据的分析.
- 探索新的治疗点,包括isolevuglandins和短链脂肪酸.
主要成果:
- 通过炎症,免疫系统在血压调节和高血压发展方面发挥着至关重要的作用.
- 针对炎症的临床试验,例如使用胆固醇,甲甲酸盐,IL-1β和TNF-α阻断的临床试验,显示出潜力,但需要进一步调查.
- 新兴的策略包括向特定的免疫成分,如isolevuglandins,并利用肠道微生物群衍生的短链脂肪酸,以实现其抗炎和降血压的作用.
结论:
- 针对特定的免疫系统途径为开发新型高血压治疗提供了一个有希望的途径.
- 单格兰丁和短链脂肪酸是未来药物开发和生活方式干预的潜在目标.
- 调节免疫系统可能会导致改善药物坚持和更好的血压控制,减少不良事件.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
01:25Antihypertensive Drugs: Direct Renin Inhibitors
508
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
508
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
492
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
492
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
600
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
600
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
139
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
139
01:18Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K